encephalitis-acute disseminated encephalomyelitis...
TRANSCRIPT
Encephalitis - Acute disseminated
Encephalomyelitis
(ADEM)
Dr. Christian Korff
1
2
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
DEFINITIONS
ENCEPHALITIS
Inflammation of the brain parenchyma
Histopathological diagnosis (inflammation,
oedema, neuronal cell death)
ENCEPHALOMYELITIS
Inflammatory process involving the brain and
spinal cord parenchyma
3
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
MECHANISMS
ADEM
• Scattered, focal or multifocal (disseminated)
areas of inflammation and demyelination
• Subcortical and deep cortical white matter
• Gray matter involvement may be seen as well
(particularly in the thalamus)
• Autoimmune + genetic predisposition?
4
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
• The encephalitis Working Group recognizes that certain clinical and neurodiagnosticfeatures may also be suggestive of acute encephalitis, allowing for a clinical diagnosis in the absence of tissue histopathology.
• It is this clinical diagnosis that is expected to be employed in the vast majority of situations utilizing these definitions.
5
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
6
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Clinical diagnosis
Brain dysfunction+
Clinical demonstration of inflammatory process
Clinical diagnosis
Brain dysfunction
• Cortical• Subcortical• Both
• Diffuse
– Consciousness, cognition,
behavior
• Focal
– Focal neurological deficits
• Both
7
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Clinical diagnosis
Inflammatory process
• Fever (> or = 38.0°C)• CSF pleocytosis
• Suggestive MRI and EEG features
8
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
EPIDEMIOLOGY
ENCEPHALITIS (overall)
� Incidence : 0.08/100’000 (hospitalbased)-7.4/100’000 (population based)
� Geographical repartition : widespread, germs vary
� Children are at higher risk than adults
9
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
EPIDEMIOLOGY
ADEM
� Incidence : 0.07/100’000 children /
year – 0.64/100’000 persons / year
� Geographical repartition : widespread
10
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ETIOLOGY
ENCEPHALITIS
Infectious
Metabolic
Autoimmune
Toxic
Neoplastic
…
Unknown: 70%!
ADEM
Post-infectious
Post-immunizations
…
Unknown: 26%!(Tenembaum, 2002)
11
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
PROGNOSIS
ENCEPHALITIS
� High risk of
neurological
sequelae
� High mortality with
certain germs: up to
33% with HSV1
12
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM
� Usually excellent
� Minor sequeleae in
10-30% of patients
1313
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS ETIOLOGY: AUTOIMMUNE
Various autoantibodies have been involved:
Glutamatergic NMDA- or AMPA-receptors
Voltage-gated potassium channels
GABAa and GABAb receptors
Glutamic acid decarboxylase
Folate receptors
…
1414
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM ETIOLOGY: IMMUNIZATIONS
Japanese encephalitis
Yellow fever
Measles
Influenza
Smallpox
Anthrax
…
• “The only epidemiologically and pathologically
proven association of an antecedent event is
with antirabies vaccination using the Semple
rabies vaccine (a vaccine derived from
sheep/mouse brains); such association has not
been observed with modern formulations of
rabies vaccine » Sejvar, 2007
15
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM ETIOLOGY: IMMUNIZATIONS
16
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS
17
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM
18
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
19
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS ADEM
+ -
20
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
• ADEM is distinguished from acute encephalitis
by
– (a) a predominance of demyelinating, rather than
cytotoxic injury
– (b) a temporal association with a specific inciting
immunogenic challenge
• Infection
• immunization
21
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
• Autoimmune encephalitis, behavioral changes
and movement disorder
IMG_0281.MOV
22
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
NMDA-R
23
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
NMDA-R
Blood: NMDA-R autoantibodies
CSF: NMDA-R autoantibodies, oligoclonal
distribution type 2 (intrathecal synthesis)
Treatments: iv methylprednisolone, iv
Immunoglobulins, plasma exchanges, rituximab
• Evolution:
– At 2 months of follow-up: no sequelae!
24
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
NMDA-R
25
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS + ADEM
26
LUMBAR PUNCTURE:
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS + ADEM
27
LUMBAR PUNCTURE:
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS ADEM
28
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
= Iliac crest = L4
LUMBAR PUNCTURE: TECHNICAL ASPECTS
29
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS + ADEM
• EEG signs compatible with encephalitis
– Diffuse, multifocal or focal epileptiform activity, or slowing
– Absent organisation and variability
30
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Herpes viruses are predominantly (but not specifically) attracted by
temporal lobes
ENCEPHALITIS (HSV) ADEM
31
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
EEG
Laoprasert, Atlas of pediatric EEG, 2011
• High signal intensity in T2, diffusion-weighted and FLAIR sequences
• Low signal intensity in T1 sequences
• Edema, cytotoxic changes, and hemorrhage suggest a viral etiology
• ADEM suggestive locations:– Periventricular white matter(50%), basal ganglia (50%), brainstem /
cerebellum / spinal cord (30-50% each)
• MRI may also be normal in both situations
32
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Early MRI features suggestive of encephalitis
33
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITISS. pneumoniae
DWI sequenceT1 sequence T2 sequence
34
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITISS. pneumoniae
DWI sequenceT1 sequence T2 sequence
35
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITISS. pneumoniae
DWI sequenceT1 sequence T2 sequence
36
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM
FLAIR sequences
37
Level 1 diagnostic certainty
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ENCEPHALITIS
38
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Level 2 diagnostic certainty
ENCEPHALITIS
39
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
Level 3 diagnostic certainty
ENCEPHALITIS
40
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
EXCLUSION CRITERIA
ENCEPHALITIS
41
Level 1 diagnostic certainty
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM
42
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEMLevel 2 diagnostic certainty
43
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEMLevel 3 diagnostic certainty
44
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
ADEM
EXCLUSION CRITERIA
45
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
46
TREATMENT (proposal)
• acyclovir, 30 mg/kg/day
+
• iv methylprednisolone, 20-30 mg/kg/day,
3-5 days
If unresponsive
• iv immunoglobulins, 2g/kg (total dose),
over 2-5 days
• plasma exchanges
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
47
ENCEPHALITIS-ADEMENCEPHALITIS-ADEM
REFERENCES
48
Thank you
Dr Christian Korff